Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia (BPH) Complicated With Lower Urinary Tract Symptoms (LUTS) -A Multicenter, Prospective, Randomized, Investigator-blind, Active Controlled Study

NCT05551221 is registered in ClinicalTrials.gov with Xintian Pharmaceutical as lead sponsor.

NCT NCT05551221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05551221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia (BPH) Complicated With Lower Urinary Tract Symptoms (LUTS) -A Multicenter, Prospective, Randomized, Investigator-blind, Active Controlled Study
Lead sponsor
Xintian Pharmaceutical
Phase
Phase 4
Overall status
Completed
Start date
September 21, 2022
Completion date
September 10, 2024
Enrollment
110 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia with lower urinary tract symptoms